cancer
immun
system
intim
relat
much
bulk
tumor
compris
stromal
leukocyt
immun
function
serv
promot
inhibit
tumor
growth
invas
metastasi
lymphocyt
adapt
immun
system
essenti
tumor
immun
cell
gener
crossprim
tumor
associ
antigen
dendrit
cell
dc
essenti
process
serv
cellular
link
innat
adapt
immun
prerequisit
prime
adapt
immun
respons
dc
must
take
tumor
antigen
process
present
context
major
histocompat
complex
mhc
dc
also
serv
sensor
innat
activ
signal
cancer
necessari
activ
effect
prime
cancer
specif
cell
discuss
role
dc
sens
cancer
prime
adapt
respons
tumor
furthermor
present
essenti
role
stimul
interferon
gene
sting
signal
pathway
produc
type
interferon
ifn
essenti
process
convent
dc
effici
crosspres
prime
cell
cellassoci
antigen
rel
low
cell
activ
potenti
shortman
heath
mous
express
high
level
mhcii
often
vatner
janssen
cancer
immun
system
intim
relat
much
bulk
tumor
compris
stromal
leukocyt
immun
function
serv
promot
inhibit
tumor
growth
invas
metastasi
lymphocyt
adapt
immun
system
essenti
tumor
immun
cell
gener
crossprim
tumor
associ
antigen
dendrit
cell
dc
essenti
process
serv
cellular
link
innat
adapt
immun
prerequisit
prime
adapt
immun
respons
dc
must
take
tumor
antigen
process
present
context
major
histocompat
complex
mhc
dc
also
serv
open
access
articl
cc
byncnd
licens
http
sensor
innat
activ
signal
cancer
necessari
activ
effect
prime
cancer
specif
cell
discuss
role
dc
sens
cancer
prime
adapt
respons
tumor
furthermor
present
essenti
role
stimul
interferon
gene
sting
signal
pathway
produc
type
interferon
ifn
essenti
process
dendrit
cell
dc
heterogen
popul
profession
antigenpres
cell
apc
hematopoiet
origin
serv
key
link
innat
adapt
immun
system
lynchpin
gener
antitumor
immun
steinman
idoyaga
dc
initi
develop
bone
marrow
express
common
myeloid
precursor
share
monocyt
macrophag
macrophagedc
progenitor
mdp
give
rise
dcrestrict
progenitor
migrat
lymphoid
organ
develop
specif
subset
dictat
transcript
regulatori
program
sens
growth
factor
eg
gmcsf
cue
local
environ
consequ
variou
dc
subtyp
display
distinct
transcript
program
morpholog
phenotyp
function
differ
tissu
differ
condit
provid
brief
overview
three
main
dc
popul
blood
born
lymphoid
dc
tissu
dc
monocytederiv
dc
encompass
inflammatori
dc
popul
involv
tumor
immun
indepth
coverag
dc
develop
lineag
subtyp
excel
review
elsewher
hashimoto
et
al
del
rio
et
al
randolph
et
al
merad
et
al
chopin
et
al
satpathi
et
al
moor
et
al
moor
anderson
liu
nussenzweig
dc
gener
separ
two
major
group
within
blood
lymphoid
tissu
mice
human
plasmacytoid
dc
pdc
convent
dc
cdc
cdc
divid
subset
base
presum
develop
myeloid
lymphoid
precursor
express
level
due
technolog
advanc
omic
multiparamet
function
phenotyp
assess
rudimentari
divis
shown
limit
properli
captur
true
varieti
dc
popul
current
movement
divid
variou
subtyp
convent
dc
two
main
categori
base
combin
lineag
express
transcript
factor
surfac
marker
approach
classif
signific
improv
primarili
develop
mice
fulli
translat
human
system
howev
clear
genom
phenotyp
pattern
exist
mous
human
dc
popul
give
confid
tool
identif
subdivid
major
dc
popul
requir
transcript
factor
develop
gener
express
mrna
toll
like
receptor
tlr
except
character
high
express
edward
et
al
human
also
express
hladr
impli
human
develop
poulin
et
al
poulin
et
al
might
affect
develop
hambleton
et
al
salem
et
al
like
mous
human
greatest
capac
crosspresent
within
human
dc
popul
poulin
et
al
crozat
et
al
jongblo
et
al
contrast
popul
mous
human
strongli
promot
cell
respons
rel
poor
capac
crosspres
cellassoci
antigen
cell
mous
human
express
sever
overlap
marker
includ
mhcii
signal
regulatori
protein
sirpa
mous
often
express
human
identifi
express
mous
shown
requir
relb
develop
role
factor
human
develop
known
dcspdc
factori
type
ifn
play
import
role
immun
respons
infect
due
capac
produc
larg
amount
type
ifn
upon
engag
mous
pdc
express
rel
low
level
mhcii
high
level
siglech
human
pdc
also
reduc
hladr
level
coexpress
human
mous
pdc
develop
requir
transcript
factor
target
gene
spib
sasaki
et
al
schott
et
al
ciss
et
al
reizi
although
function
rel
similar
human
pdc
abl
crosspres
cellassoci
antigen
contrast
mous
pdc
show
poor
capac
hoeffel
et
al
villadango
young
larg
percentag
cdc
resid
peripher
tissu
nonlymphoid
organ
help
maintain
tissu
homeostasi
promot
immun
toler
serv
first
respond
infecti
neoplast
insult
cell
gener
less
well
character
blood
lymphoid
associ
counterpart
play
import
role
antitumor
respons
repres
first
dc
popul
present
site
tumor
microenviron
merad
et
al
haniffa
et
al
kashem
et
al
mous
human
langerhan
cell
lc
resid
epidermi
share
sever
marker
mhciihladr
langerin
epcam
ecadherin
mous
lc
express
human
lc
express
studi
mice
indic
although
lc
share
mani
characterist
cdc
resist
ioniz
radiat
selfrenew
situ
lc
shown
crosspres
cellassoci
antigen
vitro
capac
vivo
establish
igyarto
kaplan
two
princip
mous
skin
dc
subset
lo
langerin
dc
hi
langerin
dc
resid
dermi
dermal
dc
capac
crosspresent
cellassoci
particul
antigen
henri
et
al
romani
et
al
bedoui
et
al
human
express
found
dermal
dc
major
cell
coexpress
interestingli
similarli
mice
dermal
dc
demonstr
superior
crosspresent
solubl
antigen
compar
dc
popul
haniffa
et
al
tissu
dcssimilar
skin
variou
dc
popul
identifi
intestin
mous
lamina
propria
contain
major
popul
dc
relat
depend
dc
relat
depend
human
analog
popul
identifi
divid
base
express
smaller
less
studi
popul
also
found
mous
human
function
poorli
understood
bekiari
et
al
like
cell
also
found
lung
langerin
dc
display
potent
capac
crosspresent
compar
like
counterpart
dc
popul
identifi
human
murin
kidney
liver
current
limit
inform
function
properti
roger
et
al
rahman
aloman
sever
tissueassoci
cdc
migrat
drain
lymph
node
lymphat
system
call
tissuemigratori
cdc
phenotyp
dc
therefor
strongli
correl
phenotyp
tissu
resid
counterpart
addit
steadi
state
dc
sever
popul
monocytederiv
dc
modc
differ
cdc
deriv
monocyt
predc
migrat
tissu
peripheri
gener
inflammatori
modc
aris
site
inflamm
local
inflammatori
cue
prompt
develop
function
capac
inflammatori
modc
found
skin
patient
atop
dermat
inflammatori
dendrit
epitheli
cell
idec
psoriasi
tnf
ino
produc
tip
dc
synovi
fluid
arthriti
patient
wollenberg
et
al
segura
amigorena
type
modc
express
mhcii
mous
hladr
human
develop
human
mous
inflammatori
modc
seem
depend
transcript
factor
growth
factor
mcsf
segura
amigorena
vivo
crosspresent
cellassoci
antigen
well
establish
subset
vitro
gener
human
mous
dc
effici
crosspres
cellassoci
solubl
antigen
rel
composit
function
tidc
strongli
dictat
tumor
microenviron
highli
dynam
depend
factor
tumor
growth
rate
vascular
hypoxia
accumul
leukocyt
cytokin
solubl
factor
secret
neoplast
cell
frequenc
tidc
correl
favor
prognosi
invers
correl
tumor
patholog
stage
varieti
cancer
karthau
et
al
ladanyi
et
al
reichert
et
al
due
role
initi
antitumor
immun
neg
select
pressur
hamper
accumul
dc
tumorsecret
mediat
inhibit
dendropoiesi
promot
dc
apoptosi
acceler
dc
turnov
esch
et
al
pirtskhalaishvili
et
al
peguetnavarro
et
al
kiertscher
et
al
moreov
tumor
microenviron
activ
exploit
variou
mechan
suppress
proinflammatori
function
infiltr
dc
even
induc
dc
suppress
immun
respons
promot
immun
toler
tumor
vascular
metastas
et
al
et
al
tran
janco
et
al
chaput
et
al
order
gener
tumorspecif
cell
respons
dc
must
endocytos
tumor
antigen
process
present
context
mhc
along
costimulatori
molecul
cytokin
mhcpeptid
complex
tumor
antigen
provid
first
three
signal
need
optim
cell
activ
mhcpeptid
complex
recogn
cognat
cell
receptor
tcr
cell
drain
lymphoid
tissu
strength
cell
activ
correl
mhcpeptid
complex
densiti
dc
well
tcr
affin
complex
peptid
antigen
second
signal
deriv
interact
membran
associ
costimulatori
molecul
synaps
cell
dc
signal
mediat
costimulatori
molecul
ligand
includ
slamslam
associ
protein
well
molecul
provid
neg
signal
review
chen
fli
absenc
suffici
costimul
signal
cell
becom
anerg
fail
respond
upon
subsequ
encount
cognat
mhc
peptid
complex
third
signal
dictat
phenotyp
function
prime
cell
mediat
paracrin
signal
solubl
cytokin
proinflammatori
eg
type
ifn
antiinflammatori
eg
help
determin
express
chemokin
receptor
integrin
facilit
cell
home
specif
target
tissu
provid
three
signal
tidc
induc
tumor
specif
immun
mediat
cell
help
elimin
primari
metastat
tumor
protect
cancer
recurr
howev
tidc
often
function
defect
impair
abil
prime
antitumor
immun
respons
even
suppress
antitumor
immun
facilit
toler
function
deficit
rang
decreas
capac
phagocytosi
reduc
antigen
process
capac
abnorm
motil
decreas
express
mhci
mhcii
proinflammatori
cytokin
costimulatori
molecul
stoitzner
et
al
diao
et
al
diao
et
al
ataera
et
al
chiba
et
al
tidc
also
often
increas
express
inhibitori
mediat
includ
cytokin
ido
ino
arginas
inhibitori
famili
member
one
central
dogma
immunolog
endogen
antigen
effici
present
context
mhci
exogen
antigen
present
context
mhcii
intriguingli
dc
abl
take
exogen
antigen
certain
context
eg
cell
associ
particul
process
load
mhci
present
cell
surfac
process
call
crosspresent
compeer
et
al
burgdorf
et
al
bevan
bevan
prevail
mechanist
hypothesi
explain
tidc
present
tumor
antigen
context
mhci
provid
signal
prime
cell
drain
lymph
node
sever
pathway
crosspresent
identifi
cytosol
pathway
close
resembl
classic
pathway
present
endogen
peptid
mhci
endogen
protein
cleav
proteasom
gener
peptid
subsequ
transloc
er
lumen
process
load
onto
newli
synthes
mhci
molecul
amigorena
savina
joffr
et
al
antigen
crosspres
mechan
taken
dc
escap
endosom
enter
cytosol
unknown
mechan
cleav
proteasom
contrast
cytosol
pathway
crosspresent
vacuolar
pathway
requir
seem
result
antigen
process
load
peptid
antigen
onto
mhci
endocyt
compart
third
mechan
involv
phagosom
fusion
also
demonstr
dc
guermonprez
et
al
ackerman
et
al
houd
et
al
sort
hybrid
cytosol
vacuolar
pathway
phagosom
combin
er
acquir
antigen
process
protein
mhci
antigen
escap
phagosom
cleav
proteasom
gener
peptid
transport
back
erphagosom
process
load
mhci
shown
capabl
crosspres
cellassoci
antigen
popul
dc
popul
crosspres
materi
target
experiment
condit
optim
present
tumor
cellassoci
antigen
seem
limit
popul
faur
et
al
nierken
et
al
thacker
janssen
sever
mechan
uncov
explain
improv
capac
crosspresent
cellassoci
antigen
includ
increas
capac
take
cellassoci
materi
alter
traffick
acidif
endocytos
materi
alter
express
compon
antigen
process
machineri
intracellular
traffick
dc
abl
recogn
endocytos
die
cell
mean
receptor
discrimin
nt
eat
signal
provid
healthi
cell
includ
recogn
findm
eatm
signal
provid
specif
entiti
dead
die
cell
review
medina
ravichandran
elliott
ravichandran
bratton
henson
liu
et
al
findm
signal
suggest
includ
atp
uridin
utp
sphingosin
lysophosphatidyl
cholin
depend
manner
cell
death
die
cell
expos
eatm
signal
continuum
dynam
distinct
cellular
chang
phosphatidyl
serin
ptdser
earli
eatm
signal
bound
directli
receptor
bai
indirectli
use
bridg
molecul
protein
addit
eatm
signal
shown
result
chang
express
oxid
lipid
alter
glycosyl
pattern
last
decad
sever
new
receptor
pathway
promot
intern
die
cell
identifi
becom
clear
express
receptor
associ
distinct
dc
popul
specif
express
link
uptak
dead
die
cell
shrimpton
et
al
sancho
et
al
ramirezortiz
et
al
zelenay
et
al
subramanian
et
al
intriguingli
use
specif
intern
receptor
shown
affect
subsequ
endosom
traffick
receptor
promot
uptak
smaller
particl
associ
slower
endosom
acidif
rate
delay
endosom
acidif
would
reduc
proteolyt
degrad
preserv
antigen
structur
therebi
provid
longer
timespan
antigen
escap
cytosol
process
compeer
et
al
thacker
janssen
ackerman
cresswel
basha
et
al
alreadi
display
increas
propens
delay
endosomallysosom
fusion
compar
dc
popul
one
easili
envis
differ
combin
dc
popul
endocyt
receptor
usag
greatli
affect
efficaci
specif
dc
capac
crosspres
cellassoci
antigen
context
mhci
dc
form
cellular
link
innat
adapt
antitumor
immun
context
appropri
matur
signal
matur
statu
dc
critic
import
induct
cell
respons
dictat
express
level
mhc
membraneassoci
solubl
costimulatori
molecul
lutz
schuler
immatur
dc
resid
peripheri
great
capac
endocytosi
express
low
level
mhc
class
ii
membran
associ
costimulatori
molecul
includ
upon
matur
dc
reduc
express
increas
express
facilit
home
drain
lymphoid
tissu
migrat
lymphat
dc
process
endocytos
antigen
present
mhc
class
ii
molecul
increas
express
mhciii
activ
costimulatori
molecul
acquir
capac
produc
proinflammatori
cytokin
chemokin
facilit
interact
antigenspecif
cell
contrast
normal
tissu
dc
essenti
function
often
impair
tidc
maintain
immatur
phenotyp
contribut
tumor
toler
suggest
result
decreas
capac
respond
normal
matur
signal
result
immun
suppress
mediat
produc
tumor
microenviron
sever
pathway
dc
matur
identifi
relev
steril
inflamm
cancer
although
signific
overlap
pathogen
sens
signal
signal
mediat
steril
inflamm
research
perform
context
infecti
pathogen
led
identif
pathogenassoci
molecular
pattern
pamp
engag
specif
pattern
recognit
receptor
prr
dc
surfac
intracellular
vesicl
dc
subset
uniqu
express
pattern
ppr
caus
dc
popul
respond
differ
upon
engag
ppr
provid
highli
modul
nuanc
immun
respons
segura
et
al
sever
famili
prr
includ
tolllik
receptor
tlr
ctype
lectin
receptor
mainli
recogn
extracellular
stimuli
cytosol
prr
includ
rigilik
receptor
rlr
nodlik
receptor
nlr
critic
import
sens
intracellular
pathogen
kawai
akira
loo
gale
elinav
et
al
osorio
rei
e
sousa
kawai
akira
pandey
et
al
matur
dc
prr
signal
cover
variou
review
provid
summari
differ
matur
signal
emphasi
sting
type
ifn
pathway
tlr
first
prr
identifi
addit
sens
pamp
also
detect
certain
marker
steril
lytic
cell
death
implic
tumor
immun
addit
infecti
process
tlr
membran
bound
receptor
includ
least
mous
human
protein
recogn
wide
rang
pamp
even
dangerassoci
molecular
pattern
damp
broader
term
includ
endogen
molecul
secret
cell
undergo
stress
releas
tissu
damag
cell
death
signal
inflamm
prokaryot
product
recogn
includ
lipoprotein
lipopolysaccharid
flagellin
cell
surfac
membran
intracellular
vesicleassoci
tlr
recogn
dsrna
singl
strand
rna
ssrna
dna
depend
type
tlr
signal
requir
one
sever
adapt
molecul
trif
tirap
tram
follow
activ
downstream
mediat
ultim
induc
transloc
ifnregulatori
factor
irf
includ
kawai
akira
kawai
akira
receptor
induc
rapid
transcript
inflammatori
cytokin
includ
type
ifn
nonmammalian
carbohydr
mannos
acetylglucosamin
form
one
class
pamp
recogn
ctype
lectin
receptor
osorio
rei
e
sousa
receptor
cluster
activ
group
signal
immunoreceptor
tyrosinebas
activ
itam
like
motif
itambind
fcrg
adaptor
molecul
inhibitori
group
mediat
effect
immunoreceptor
tyrosinebas
inhibit
itim
motif
import
sens
mani
bacteria
less
relev
innat
immun
sens
cancer
nodlik
receptor
nlr
encompass
group
cytosol
innat
sensor
predominantli
recogn
bacteri
cell
compon
upon
engag
cognat
ligand
nlr
oligomer
scaffold
known
inflammasom
activ
subsequ
function
cleav
proinflammatori
famili
cytokin
bioactiv
form
receptor
alr
famili
contain
sever
sensor
cytoplasm
dna
includ
like
nlr
function
inflammasom
complex
promot
cleav
proinflammatori
famili
cytokin
interestingli
homolog
mous
bind
dsdna
form
inflammasom
signal
via
sting
induct
type
ifn
inflammatori
mediat
retino
acid
induc
gene
rigi
like
receptor
anoth
famili
prr
compris
dexdh
box
rna
helicas
play
import
role
antivir
immun
detect
viral
associ
rna
loo
gale
famili
encompass
cytosol
protein
rigi
bind
rna
short
doubl
strand
rna
dsrna
melanoma
differenti
associ
protein
recogn
long
dsrna
rigi
signal
via
caspas
activ
recruit
domain
card
mitochondri
antivir
signal
domain
mav
also
known
cardif
subsequ
stimul
ikk
pathway
result
induct
inflammatori
cytokin
addit
studi
indic
specif
virus
rigi
pathway
converg
sting
pathway
potenti
antivir
respons
recent
sting
identifi
import
regul
immun
mediat
type
ifn
product
respons
cytosol
dna
burdett
vanc
ishikawa
et
al
sting
protein
sensor
cytosol
dna
anchor
er
initi
studi
suggest
sting
may
sens
dna
structur
directli
wide
accept
cytosol
dna
bind
molecul
upstream
sting
requir
activ
pathway
cyclicgmpamp
synthas
cga
consid
predomin
dna
sensor
pathway
upon
bind
dna
cytosol
cga
catalyz
synthesi
cyclic
gmpamp
cgamp
guanosin
triphosph
gtp
adenosin
triphosph
atp
ablass
et
al
civril
et
al
cgamp
function
second
messeng
bind
activ
sting
result
traffick
er
golgi
perinuclear
endosom
mediat
subsequ
signal
via
phosphoryl
tankbind
kinas
induc
transcript
type
ifn
inflammatori
gene
fig
cgascgamp
pathway
consid
domin
pathway
evid
sensor
recogn
cytosol
dna
associ
viral
infect
use
pathway
induc
type
ifn
respons
among
dnadepend
activ
ifnregulatori
factor
dai
dexdhbox
rna
helicas
dna
depend
protein
kinas
dnapk
protein
human
mous
impli
dampsa
immun
respons
pathogen
infect
dc
must
appropri
activ
order
prime
cell
respons
cancer
howev
uptak
die
cell
gener
consid
tolerogen
event
order
maintain
tissu
homeostasi
prevent
develop
autoimmun
disord
dc
phagocytos
die
cell
report
produc
immunesuppress
cytokin
significantli
inhibit
capac
produc
proinflammatori
cytokin
upregul
costimulatori
molecul
one
mechan
sens
cancer
develop
inflamm
steril
environ
involv
releas
endogen
molecul
serv
damp
signal
prr
sens
pathogen
deriv
molecul
damp
encompass
cellular
compon
factor
either
present
death
releas
die
cell
gener
result
cellular
stress
exampl
includ
atp
may
engag
nod
inflammasom
suggest
signal
filament
actin
recogn
well
heat
shock
protein
uric
acid
zhang
et
al
normal
intracellular
reach
dc
physiolog
condit
damp
serv
danger
signal
releas
extracellular
milieu
stress
die
cancer
cell
damp
access
dc
presenc
signifi
loss
integr
cell
membran
suggest
tissu
damag
caus
noxiou
origin
infect
mechan
injuri
hypoxia
cancer
vaccin
anim
model
downstream
signal
adaptor
implic
immun
respons
cancer
induc
radiat
certain
chemotherapi
howev
model
found
necessari
suffici
develop
immun
respons
cancer
recent
type
ifn
product
signal
sting
pathway
identifi
essenti
role
develop
antitumor
immun
respons
tumor
deriv
dna
protect
integr
genet
inform
encod
dna
primari
prerog
live
organ
sinc
incept
sens
threat
form
dna
damag
radiat
exposur
oxid
stress
viral
infect
essenti
maintain
continu
line
genet
inform
cell
maintain
potenti
especi
apc
dc
respond
dna
damag
cytosol
dna
produc
type
ifn
addit
recognit
dsdna
sever
report
suggest
sting
promot
type
ifn
product
upon
rnaviru
infect
interact
rna
sens
pathway
compon
mav
nazmi
et
al
sun
et
al
howev
evid
sting
pathway
dc
activ
rna
upon
uptak
dead
die
cell
avail
type
ifn
signal
dc
shown
promot
capac
prime
crossprim
cell
sever
way
type
ifn
cytokin
potent
activ
dc
phenotyp
function
effect
three
signal
need
gener
robust
cell
respons
type
ifn
collect
protein
well
signal
common
interferon
receptor
ifnar
essenti
nucleat
cell
express
ifnar
heterodim
includ
two
distinct
subunit
bind
ifn
receptor
lead
dimer
two
subunit
result
auto
phosphoryl
tyrosin
kinas
janu
activ
kinas
jak
activ
signal
transduc
activ
transcript
stat
theofilopoulo
et
al
activ
stat
protein
dimer
rapidli
transloc
nucleu
bind
ifnstimul
respons
element
isr
initi
transcript
hundr
ifnsensit
gene
isg
type
ifn
facilit
crossprim
dc
varieti
mechan
promot
antigen
persist
reduct
endosomallysosom
acidif
rate
thu
facilit
storag
exogen
acquir
cellassoci
antigen
compart
thacker
janssen
lorenzi
et
al
furthermor
type
ifn
promot
transcript
translat
immunoproteasom
subunit
shin
et
al
shin
et
al
modifi
peptidas
activ
constitut
proteasom
chang
repertoir
peptid
bind
present
mhci
addit
treatment
promot
local
mhci
molecul
antigen
storag
compart
dc
enhanc
antigen
present
spadaro
et
al
addit
effect
antigen
persist
process
load
type
ifn
also
increas
overal
surfac
express
level
mhci
mhcii
well
membran
associ
costimulatori
molecul
moreov
type
ifn
serv
signal
cytokin
enhanc
cell
prime
signal
within
cell
agarw
et
al
curtsing
mescher
xiao
et
al
tabl
murin
model
type
ifn
seem
requir
antitumor
immun
dunn
et
al
demonstr
mice
lack
ifnar
suscept
carcinogeninduc
tumor
mice
treat
antiifnar
antibodi
much
suscept
transplant
tumor
outgrowth
mice
given
isotyp
control
dunn
et
al
dunn
et
al
fuert
et
al
discov
spontan
antitumor
cell
respons
defect
mice
lack
either
ifnar
transcript
factor
immedi
downstream
ifn
signal
fuert
et
al
studi
mice
lack
ifnar
specif
dc
lack
dc
popul
demonstr
antitumor
respons
depend
dc
diamond
et
al
hildner
et
al
klarquist
et
al
possibl
certain
role
type
ifn
immun
respons
human
cancer
strong
correl
data
suggest
import
human
patient
metastat
melanoma
metastat
lesion
infiltr
cell
character
ifn
gene
signatur
fuert
et
al
harlin
et
al
inflam
phenotyp
associ
inhibitori
factor
suppress
cell
function
respons
immunotherapi
includ
checkpoint
inhibitor
target
ji
et
al
topalian
et
al
type
ifn
gene
signatur
primari
tumor
diagnosi
also
found
associ
improv
prognosi
respons
anthracyclin
chemotherapi
women
breast
cancer
sistigu
et
al
associ
support
studi
murin
model
demonstr
breast
cancer
like
metastas
bone
pathway
block
bidwel
et
al
pattern
also
hold
studi
cancer
vaccin
similar
gene
signatur
found
correl
improv
clinic
respons
aggreg
find
support
relev
type
ifn
respons
human
patient
fact
motiv
much
work
highlight
import
ifn
anim
model
ulloamontoya
et
al
signal
sting
pathway
essenti
precursor
gener
type
ifn
need
spontan
treatment
induc
cancer
immun
respons
dna
sens
sting
upstream
link
trigger
type
ifn
product
dc
facilit
effect
crossprim
tumor
specif
cell
dna
like
deriv
stress
die
cancer
cell
introduc
dc
cytosol
yet
unknown
mechan
bind
cga
initi
sting
mediat
type
ifn
transcript
fig
import
pathway
demonstr
varieti
tumor
model
includ
colon
carcinoma
melanoma
lymphoma
woo
et
al
sting
also
requir
spontan
reject
immunogen
sarcoma
author
nice
explor
mechan
show
sting
pathway
activ
host
dc
result
sens
tumor
deriv
dna
woo
et
al
woo
et
al
find
extend
tumor
model
coliti
induc
cancer
sting
defici
mice
increas
suscept
colon
cancer
oncogenesi
respons
inflamm
zhu
et
al
ahn
et
al
mous
model
spontan
develop
intracrani
glioma
loss
function
mutat
sting
result
reduc
product
type
ifn
myeloid
cell
impair
tumor
control
immun
system
ohkuri
et
al
dna
damag
like
stimulu
activ
sting
transcript
type
ifn
breast
cancer
model
defect
dna
damag
repair
found
accumul
dna
cytosol
activ
ifn
respons
sting
depend
manner
park
et
al
tumor
impair
dna
damag
repair
grown
mice
develop
cell
infiltr
compar
wild
type
breast
cancer
tumor
approach
shown
requir
dcstingifn
pathway
effect
radiat
therapi
prime
exampl
ioniz
radiat
long
known
select
kill
cancer
cell
use
cancer
treatment
local
tumor
control
centuri
cytotox
damag
genom
dna
thought
princip
mechan
effect
radiotherapi
recent
evid
emerg
implic
immun
system
tumor
control
mediat
radiat
apetoh
et
al
burnett
weichselbaum
burnett
et
al
lee
et
al
furthermor
focal
irradi
tumor
activ
dc
induc
crossprim
tumor
specif
cell
mediat
system
antitumor
immun
demaria
et
al
gupta
et
al
lim
et
al
lugad
et
al
weichselbaum
et
al
radiat
induc
antitumor
immun
respons
depend
sting
upstream
mediat
cga
deng
et
al
tumor
mice
lack
gene
control
otherwis
effect
dose
radiat
dc
produc
type
ifn
respons
radiat
defect
crossprim
tumor
specif
cell
radiotherapi
radiat
therapi
mani
antineoplast
chemotherapi
agent
induc
cytotox
damag
chromosom
dna
fibroblast
treat
arac
undergo
dna
damag
nuclear
dna
transport
cytosol
sens
sting
trigger
type
interferon
respons
lan
et
al
chemotherapi
agent
etoposid
also
direct
affect
dc
caus
dna
damag
transport
dna
cytosol
also
elicit
stingdepend
type
interferon
respons
differ
class
chemotherapi
agent
induc
differ
type
dna
damag
one
specul
chemotherapeut
agent
support
format
ligand
sting
pathway
would
provid
clinic
benefit
facilit
antitumor
immun
howev
current
littl
known
induct
sting
ligand
type
ifn
induc
capac
main
dna
damag
chemotherapi
agent
recent
studi
indic
effect
sting
activ
promot
tumor
immun
protect
sting
agonist
also
promot
oncogenesi
exampl
mice
treat
cutan
anthracen
dmba
develop
inflamm
skin
cancer
mediat
sting
ahn
et
al
sting
also
modifi
tumor
microenviron
becom
tolerogen
promot
tumor
progress
metastasi
induct
ido
promot
treg
function
immun
toler
tumor
cytokin
lemo
et
al
huang
et
al
point
clear
circumst
sting
type
ifn
promot
suppress
antitumor
immun
although
chronic
inflamm
well
accept
stimulu
oncogenesi
one
specul
complex
tumor
microenviron
variou
regulatori
compon
treg
myeloid
deriv
suppressor
cell
macrophag
may
help
determin
effect
ifn
stimul
recent
year
pharmacolog
agent
activ
sting
pathway
use
mimic
augment
role
sting
mediat
product
type
ifn
antitumor
immun
administr
sting
ligand
cdigmp
dmxaa
cgamp
cdn
significantli
improv
antitumor
respons
anim
surviv
divers
array
mous
model
solid
blood
born
cancer
deng
et
al
baird
et
al
chandra
et
al
corral
et
al
curran
et
al
dmxaa
sting
agonist
multifacet
effect
tumor
microenviron
treatment
melanoma
dmxaa
augment
tumorspecif
cell
respons
effect
immun
protect
mice
futur
tumor
challeng
similar
result
seen
mous
model
prostat
breast
cancer
well
sarcoma
baguley
ching
light
promis
result
anim
model
dmxaa
test
clinic
trial
patient
nonsmal
cell
lung
cancer
unfortun
dmxaa
bind
human
sting
thu
unabl
activ
pathway
result
neg
trial
lara
et
al
gao
et
al
anoth
sting
agonist
cyclic
diguanyl
nucleotid
cdn
cdigmp
effect
treatment
mammari
carcinoma
synthet
cdn
agonist
cda
high
affin
human
murin
sting
stimul
type
ifn
product
human
pbmc
agent
induc
immun
mediat
tumor
reject
melanoma
breast
colon
carcinoma
mice
cdn
base
sting
agonist
also
use
conjunct
gvac
cancer
vaccin
along
antagonist
result
addit
effect
tumor
immun
fu
et
al
open
new
avenu
addit
novel
therapi
includ
nt
eat
signal
blockad
shown
critic
depend
ifnst
pathway
liu
et
al
describ
radiotherapi
induc
dna
damag
sens
tidc
sting
pathway
current
mani
preclin
sever
clinic
studi
util
radiat
stimul
antitumor
immun
sinc
radiotherapi
alon
rare
induc
antitumor
immun
respons
result
system
control
metastat
diseas
therapeut
effect
radiat
innat
adapt
immun
system
larg
explor
combin
immunotherapi
modal
initi
studi
demonstr
synergist
effect
radiat
combin
immun
modul
perform
demaria
formenti
group
observ
improv
tumor
control
within
irradi
field
object
respons
distant
site
diseas
use
ligand
antibodi
antagonist
checkpoint
receptor
breast
cancer
colon
cancer
model
demaria
et
al
demaria
et
al
dewan
et
al
demaria
et
al
similar
find
anim
model
combin
radiat
inhibitor
dc
vaccin
immun
modul
observ
mechanist
studi
perform
multipl
group
deng
et
al
filatenkov
et
al
sharabi
et
al
sharabi
et
al
vatner
et
al
yoshimoto
et
al
one
studi
even
combin
radiat
therapi
pharmacolog
sting
agonist
found
improv
tumor
control
antitumor
immun
suggest
radiat
provid
uniqu
ingredi
product
antitumor
immun
beyond
sting
activ
baird
et
al
anim
studi
translat
success
preliminari
clinic
trial
patient
metastat
cancer
mani
ongo
trial
test
patient
varieti
malign
trial
combin
radiat
immun
checkpoint
inhibitor
goal
prime
tumor
specif
cell
radiat
boost
cell
respons
checkpoint
inhibitor
overcom
suppress
microenviron
preliminari
result
appear
promis
matur
result
trial
pend
golden
et
al
radiotherapi
alway
question
optim
dose
use
mani
treatment
deliv
fraction
activ
sting
initi
immun
respons
activ
question
field
howev
preclin
studi
even
fewer
clinic
trial
compar
differ
dose
fraction
treatment
schedul
origin
studi
demaria
group
explor
dose
fraction
find
gy
deliv
three
fraction
gy
result
robust
system
tumor
control
compar
gy
five
fraction
singl
fraction
gy
dewan
et
al
recent
studi
group
explor
mechanist
underpin
singl
larger
fraction
gy
radiat
effect
three
fraction
gy
found
treatment
result
transport
dsdna
cytosol
tumor
cell
sens
cga
activ
sting
type
ifn
transcript
vanpouillebox
et
al
howev
larger
dose
radiat
induc
three
prime
exonucleas
degrad
cytosol
dna
limit
sting
activ
ifn
respons
studi
group
compar
singl
fraction
treatment
fraction
treatment
shown
conflict
result
howev
util
singl
fraction
treatment
dose
gy
appar
threshold
activ
beyond
dose
fraction
question
remain
optim
applic
radiat
therapi
stimul
sting
mediat
tumor
immun
question
includ
import
anatom
locat
target
lesion
whether
better
treat
primari
tumor
metastat
site
effect
radiat
dose
rate
effect
differ
modal
energi
ioniz
radiat
eg
photon
vs
proton
vs
electron
question
remain
work
role
immun
system
combat
cancer
topic
specul
debat
past
centuri
mount
experiment
evid
support
function
immun
system
howev
recent
year
success
cancer
immunotherapi
appli
patient
care
cancer
immun
receiv
widespread
accept
immun
system
alert
presenc
cancer
one
central
question
cancer
immunolog
dc
link
innat
adapt
immun
system
prime
cell
respons
cellular
antigen
context
inflammatori
signal
debat
regard
natur
inflammatori
signal
respons
tumor
recent
evid
summar
review
support
hypothesi
damag
dna
releas
cancer
cell
stimulu
gener
tumor
immun
dna
gain
access
cytoplasm
dc
recogn
cga
trigger
sting
product
type
ifn
necessari
effect
crossprim
cell
tumor
antigen
primaci
dna
sens
stimulu
dc
activ
respons
cancer
help
inform
ontolog
question
cancer
immunolog
cancer
histor
view
pathogen
process
separ
host
organ
even
concept
tumor
host
suggest
other
cancer
think
natur
led
search
danger
signal
produc
respons
cancer
broaden
understand
innat
immun
mean
detect
self
nonself
pamp
gener
view
mean
detect
danger
absenc
danger
damp
fact
dc
sens
damag
dna
rather
damp
associ
lytic
cell
death
place
immun
respons
cancer
realm
assault
integr
genom
rather
exogen
pathogen
although
much
mechan
sens
cancer
deriv
dna
via
sting
pathway
dc
elucid
mani
question
remain
one
question
relat
tumor
dna
taken
dc
gain
access
dc
cytosol
may
coincid
dc
popul
effici
crosspresent
exhibit
delay
endosom
acidif
seem
explicitli
implic
sting
depend
induct
type
ifn
one
envis
mechan
dna
escap
endosom
compart
analog
manner
endocytos
protein
escap
cytosol
process
peptid
present
mhci
anoth
unansw
question
relat
natur
direct
upstream
signal
molecul
bind
cytosol
dna
engag
sting
could
target
therapeut
benefit
also
intrigu
sting
activ
promot
antitumor
immun
model
other
suppress
immun
respons
tumor
promot
toler
excit
time
tumor
immunolog
see
scientif
understand
cancer
translat
human
clinic
trial
applic
therapi
target
sting
pathway
mimic
enhanc
endogen
immun
respons
cancer
current
underway
result
trial
help
enhanc
understand
cancer
immun
offer
hope
futur
enlist
immun
system
fight
cancer
sting
signal
pathway
cytosol
dna
primarili
sens
cyclicgmpamp
synthas
cga
gener
cyclic
gmpamp
cgamp
guanosin
triphosph
gtp
adenosin
triphosph
atp
cgamp
function
second
messeng
bind
activ
sting
result
traffick
er
golgi
perinuclear
endosom
mediat
subsequ
signal
via
phosphoryl
tankbind
kinas
induc
transcript
type
ifn
inflammatori
gene
dnapk
also
act
sensor
cytosol
dna
similar
downsream
effect
sting
page
mol
immunol
author
manuscript
avail
pmc
septemb
stingmedi
induct
type
ifn
dc
upon
sens
tumor
dna
dna
damag
therapi
result
induct
cell
death
nucleosom
releas
mitochondri
damag
endocytos
dc
upon
escap
endosom
tumorderiv
dna
cytosol
tumordna
interact
cga
result
induct
cdn
activ
sting
downstream
signal
sting
induc
proinflammatori
gene
includ
type
ifn
parallel
protein
escap
endosom
degrad
promot
crosspresent
mhc
class
immun
respons
depend
type
ifn
sting
damp
dna
